tradingkey.logo

Treace Medical Concepts Inc

TMCI
查看詳細走勢圖
2.420USD
-0.020-0.82%
收盤 12/26, 16:00美東報價延遲15分鐘
154.17M總市值
虧損本益比TTM

Treace Medical Concepts Inc

2.420
-0.020-0.82%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.82%

5天

-5.84%

1月

-19.60%

6月

-57.91%

今年開始到現在

-67.47%

1年

-65.33%

查看詳細走勢圖

TradingKey Treace Medical Concepts Inc股票評分

單位: USD 更新時間: 2025-12-26

操作建議

Treace Medical Concepts Inc當前公司基本面數據相對穩定,增長潛力較大。當前估值合理,在醫療設備與耗材行業排名124/207位。機構持股佔比非常高,近一個月多位分析師給出公司評級為持有。最高目標價5.47。中期看,股價處於下降通道。近一個月,市場表現非常差,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Treace Medical Concepts Inc評分

相關信息

行業排名
124 / 207
全市場排名
313 / 4563
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

分析師目標

基於 6 分析師
持有
評級
5.470
目標均價
+109.58%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Treace Medical Concepts Inc亮點

亮點風險
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
業績高增長
公司營業收入穩步增長,連續3年增長47.60%
利潤高增長
公司淨利潤處於行業前列,最新年度總收入209.36M美元
估值高估
公司最新PE估值-3.05,處於3年歷史高位
機構減倉
最新機構持股38.30M股,環比減少33.15%
PRFDX持倉
明星投資者PRFDX持倉,最新持倉4.87K股

Treace Medical Concepts Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Treace Medical Concepts Inc簡介

Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
公司代碼TMCI
公司Treace Medical Concepts Inc
CEOTreace (John T)
網址https://www.treace.com/

常見問題

Treace Medical Concepts Inc(TMCI)的當前股價是多少?

Treace Medical Concepts Inc(TMCI)的當前股價是 2.420。

Treace Medical Concepts Inc 的股票代碼是什麼?

Treace Medical Concepts Inc的股票代碼是TMCI。

Treace Medical Concepts Inc股票的52週最高點是多少?

Treace Medical Concepts Inc股票的52週最高點是10.790。

Treace Medical Concepts Inc股票的52週最低點是多少?

Treace Medical Concepts Inc股票的52週最低點是2.360。

Treace Medical Concepts Inc的市值是多少?

Treace Medical Concepts Inc的市值是154.17M。

Treace Medical Concepts Inc的淨利潤是多少?

Treace Medical Concepts Inc的淨利潤為-55.74M。

現在Treace Medical Concepts Inc(TMCI)的股票是買入、持有還是賣出?

根據分析師評級,Treace Medical Concepts Inc(TMCI)的總體評級為持有,目標價格為5.470。

Treace Medical Concepts Inc(TMCI)股票的每股收益(EPS TTM)是多少

Treace Medical Concepts Inc(TMCI)股票的每股收益(EPS TTM)是-0.794。
KeyAI